Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

May 27, 2016May 27, 2016

New Protein That Regulates T Cell Responses May Bring New Therapies for RA

News

Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) and colleagues have identified a protein that regulates T cell responses, which might explain why the immune system sometimes fails ... Read more

May 11, 2016May 11, 2016

RA Patients in UK Seen to Largely Ignore Flu and Pneumonia Vaccine Guidelines

News

University of Manchester researchers investigating how closely rheumatoid arthritis (RA) patients adhere to influenza and pneumococcal vaccination guidelines, found only suboptimal compliance — a factor that greatly contributes to their high risk of contracting such infections. The ... Read more

May 6, 2016May 6, 2016

Salt-Inducible Kinases, a Type of Enzyme, Seen as Inflammatory Target in Early Study

News, rheumatoid arthritis

Researchers found that inhibition of certain type of enzymes, the salt-inducible kinases, significantly reduces the production of inflammatory molecules and promotes an immune cell phenotype characterized by anti-inflammatory agents. The findings ... Read more

April 18, 2016April 18, 2016

B-Cells in Rheumatoid Arthritis Bone Erosion Lead to Identification of Novel Biomarker

News

University of Rochester Medical Center researchers have studied the joint tissue of rheumatoid arthritis (RA) patients, finding that B-cells in these tissues play an important role in bone erosion, contributing ... Read more

April 12, 2016April 13, 2016

High-fat Diets Tied to Diseases Like Rheumatoid Arthritis Through Disruption of Cells’ Circadian Rhythm

News

The consumption of saturated fats — and when in the day they are eaten — dysregulate the circadian rhythm of cells, essentially “jet-lagging” them, and promote chronic low-grade inflammation and metabolic diseases ... Read more

March 16, 2016March 16, 2016

Rheumatoid Arthritis Research Indicates Serotonin Could Be New Target for Therapies

News

Researchers have shown for the first time that serotonin plays a fundamental role in the pathology of rheumatoid arthritis, through the regulation of essential regulatory immune cells and cells responsible ... Read more

February 3, 2016February 3, 2016

Inflammation During Pregnancy Linked to Autism Through Immune Response

News

Pregnant women who develop severe infections are known to more frequently give birth to children with autism, and a collaborative team of researchers working with a mouse model have identified a possible ... Read more

January 20, 2016January 20, 2016

Rheumatoid Arthritis Gene-Regulating Mechanisms Uncovered

News

Yale School of Medicine researchers have uncovered the molecular key players that regulate a gene known to be linked to susceptibility to infectious and autoimmune diseases such as rheumatoid arthritis. The ... Read more

January 8, 2016January 8, 2016

Maple Syrup Molecule has Anti-Inflammatory Properties, Possible Rheumatoid Arthritis Treatment

News

Researchers at Canada’s Université Laval have demonstrated the powerful anti-inflammatory effects of quebecol, a maple syrup compound, along with its derivatives, offering promise for the development of anti-inflammatory therapies targeting autoimmune diseases ... Read more

January 4, 2016January 4, 2016

Rheumatoid Arthritis Patients May Be Identified by Finger-Vein Patterns

News

Connective tissue diseases affect finger-vein patterns, pointing to these patterns as a possible biometric authentication technique and diagnostic tool in rheumatoid arthritis (RA). These are the conclusions of a study, “Personal Authentication ... Read more